UFPT
UFP Technologies, Inc. · Healthcare · Medical - Devices
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -5.1% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 84 | 0 | 5.60M | $1.48B | +5 | −5 |
| Q1 2026 | 87 | -2 | 5.05M | $977.88M | +5 | −7 |
| Q4 2025 | 89 | -3 | 5.34M | $1.19B | — | −3 |
| Q3 2025 | 18 | 0 | 2.83M | $564.24M | — | — |
| Q2 2025 | 15 | +2 | 2.67M | $652.20M | +2 | — |
| Q1 2025 | 10 | -1 | 1.10M | $222.08M | +1 | −2 |
| Q4 2024 | 11 | 0 | 1.06M | $258.43M | +1 | −1 |
| Q3 2024 | 10 | 0 | 609.62K | $193.08M | +1 | −1 |
| Q2 2024 | 10 | — | 642.12K | $169.45M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 279.42K | -4.8% | $88.49M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 173.00K | +2.0% | $54.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 173.00K | +2.0% | $54.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 114.51K | +7.2% | $36.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 114.51K | +7.2% | $36.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Arrowstreet Capital ✦ | 13.37K | New | $4.24M | 0.0% | New | 1 | SEC ↗ |
| 7 | Millennium Management ✦ | 9.93K | -62.8% | $3.14M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Marshall Wace ✦ | 9.85K | +7.8% | $3.12M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 3.49K | -52.2% | $1.10M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 3.49K | -52.2% | $1.10M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Bridgewater Associates ✦ | 3.39K | -43.3% | $1.07M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 1.83K | -2.4% | $578,611 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 1.83K | -2.4% | $578,611 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 835 | 0.0% | $264,445 | 0.0% | Held | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Arrowstreet Capital | $4.24M | 0.0% |
Exited
| Wellington Management | $5.33M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 271 holders, 8.76M shares, $1.58B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 298 sh · $95,095
Director · 1.93K sh · $625,141
Director · 1.00K sh · $324,260
Officer, Director · 6.87K sh · $2.17M
Officer, Director · 5.77K sh · $1.82M
Officer, Director · 374 sh · $118,659
Officer, Director · 542 sh · $170,763
Officer, Director · 4.47K sh · $1.42M
Officer, Director · 7.88K sh · $2.51M
Officer, Director · 2.81K sh · $897,740
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology